Point-of-care progress Ildikó Amann-Zalán, head of R&D for Roche Diagnostic Solutions, also provided updates on launches within the firm's near-patient care segment. The company is seeking Emergency ...

That largely has not happened. The point-of-care molecular testing market was inaugurated in 2015 with the clearance and CLIA waiver of the Abbott ID Now isothermal platform, followed by the Roche ...

Antigua-based regional carrier LIAT 2020, which launched operations in April 2024 as the successor to LIAT (1974) Limited, is experiencing lowerthan- expected passenger loads into Barbados since ...

Roche and AbbVie have come up short again in their effort to gain an additional indication for their blockbuster blood cancer treatment Venclexta. A phase 3 trial of the therapy in previously ...

Roche, a partner of Prothena Corporation plc (NASDAQ:PRTA), has announced plans to initiate Phase 3 development of prasinezumab for early-stage Parkinson’s disease.

FRANKFURT, May 26 (Reuters) - Swiss drugmaker Roche (ROG.S), opens new tab said on Monday it would advance testing of an antibiotic against a common drug-resistant bacteria that causes serious ...

Tandem Diabetes Care, Inc. (NASDAQ:TNDM) has agreed to pay Roche $36 million to resolve a patent infringement lawsuit over Tandem's t:slim X2 insulin pump. A hospital room with a patient using a ...

Roche Holding (OTCQX:RHHBY) subsidiary Genentech and AbbVie (ABBV) announced an update relating to the development of their randomized global phase 3 VERONA study, which was to evaluate the use of ...

Why is Christian Science in our name? Our name is about honesty. The Monitor is owned by The First Church of Christ, Scientist, and we’ve always been transparent about that. The church publishes ...